Public research footprint of Hospital Universitario Puerta de Hierro, compiled from the ClinicalTrials.gov public registry.
Neovascular Age-related Macular Degeneration (nAMD) · Heart Failure · Non-Small Cell Lung Cancer (NSCLC) · Triple-Negative Breast Cancer
Enter your work email to view the full list.
Verify and correct how your facility appears in public registry records — free.
Verify this profile →Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.